Lumen Bioscience, Inc.
Lumen Bioscience is dedicated to unlocking the full potential of biologic drugs by transforming their development, cost, and accessibility. Utilizing patented technology, Lumen aims to develop biologic drugs faster, safer, and more effectively than traditional methods, addressing diseases that have been neglected by conventional drug-making tools.
Lumen Bioscience, Inc. is currently seeking investment
Lumen Bioscience, Inc. is seeking a investment in the range of
What We Do
Lumen Bioscience partners with pharmaceutical companies to discover, develop, and manufacture biologic drugs for highly prevalent diseases, many of which currently lack effective treatments. Their unique development and GMP biomanufacturing technology platform allows for accelerated time from concept to clinic and lower costs compared to conventional approaches.
Drugs
Biologics
Services
Vaccines
Funded Projects
Ultra-Rapid, Low-Cost Neutralizing Antibody Therapeutic for COVID-19
COVID-19 is a significant force readiness issue for the United States military. In response, Lumen Bioscience has started developing and testing a low-cost, orally delivered cocktail of antibodies against SARS-CoV-2 (the virus that causes COVID-19) to prevent and treat infection of the gastrointestinal tract. A gastrointestinal-targeted therapy could reduce overall viral burden, inhibit disease progression, accelerate viral clearance, and block significant transmission routes.
News & Updates
Recognition of award winners at the MTEC Membership Meeting.
Podcast discussing innovation challenges in biotech with Lumen's Brian Finrow.
Article detailing Lumen's advancements in using spirulina for biologic drug production.
Discussion on simplifying drug development processes.